SCHEMBL25463237

SCHEMBL25463237

CC(=O)c1ccc(-c2noc(C)n2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.69
LMNA P02545 3/20 0.61
RAB9A P51151 2/20 0.61
TSHR P16473 1/20 0.61
NFKB1 P19838 1/20 0.61
NFKB2 Q00653 1/20 0.61
RELA Q04206 1/20 0.61
HTT P42858 2/20 0.57
HPGD P15428 1/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
BRD4 O60885 1/20 0.54
SMYD3 Q9H7B4 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
THRB P10828 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
MAPK14 Q16539 2/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27574154 0.87 PLK1 (0.71) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL326978 0.86 PLK1 (0.69) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL13415301 0.84 L3MBTL1 (0.69) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL1021042 0.84 PLK1 (0.67) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL6807698 0.84 PLK1 (0.67) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL5843831 0.84 PLK1 (0.67) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL8792955 0.83 PLK1 (0.65) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL11962152 0.81 PLK1 (1.00) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL13938063 0.81 PLK1 (0.68) PLK1LMNARAB9ATSHRNFKB1
SCHEMBL7554084 0.80 PLK1 (0.97) PLK1LMNARAB9ATSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183171-A1 PREPARATION OF SUBSTITUTED 4-(N'-HYDROXYCARBAMIMIDOYL)BENZOIC ACIDS BASF CHEMICALS INDIA PVT. LTD. (IN) 2023-06-15 US disclosed
US-20230145982-A1 PREPARATION OF SUBSTITUTED 3-ARYL-5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLES BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230145982-A1 PREPARATION OF SUBSTITUTED 3-ARYL-5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLES CYP4F3, ACOX3, PEX3 PLK1 3946/4885LMNA 2430/4885RAB9A 4076/4885
US-20230183171-A1 PREPARATION OF SUBSTITUTED 4-(N'-HYDROXYCARBAMIMIDOYL)BENZOIC ACIDS PAH, HAAO, HNMT PLK1 4531/4885LMNA 2011/4885RAB9A 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.